Skip to main content
Peter Scardino, MD, Urology, New York, NY

Peter T Scardino MD FACS


David H. Koch Chair, Attending Urologist, Dept. of Surgery

Join to View Full Profile
  • Memorial Sloan Kettering Cancer CenterKimmel Center for Prostate and Urologic Cancer, 353 E. 68th StNew York, NY 10065

  • Phone+1 646-422-4329

  • Fax+1 646-422-1095

Dr. Scardino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1979
  • Clinical Center at the National Institutes of Health
    Clinical Center at the National Institutes of HealthFellowship, Complex General Surgical Oncology, 1976
  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalResidency, Surgery, 1971 - 1973
  • Duke University School of Medicine
    Duke University School of MedicineClass of 1971

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - Present
  • NY State Medical License
    NY State Medical License 1998 - 2027
  • NJ State Medical License
    NJ State Medical License 2021 - 2023
  • TX State Medical License
    TX State Medical License 1979 - 2000
  • MD State Medical License
    MD State Medical License 1973 - 1983
  • Urology
    American Board of Urology Urology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Sunrise Ambulatory Care, Allscripts, 2016
  • CMS Meaningful Use Stage 1 Certification MyMSK, Memorial Sloan Kettering, 2016
  • Ramon Guteras Award American Urological Association, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-S...  
    John P Mulhall, Eric A Klein, Kevin Slawin, Peter T Scardino, The Journal of Sexual Medicine

Authored Content

  • The Duration of Antibiotics Prophylaxis at the Time of Catheter Removal After Radical Prostatectomy: Clinically-Integrated, Cluster, Randomized TrialApril 2021
  • Tumor Copy Number Alteration Burden Is a Pan-Cancer Prognostic Factor Associated with Recurrence and DeathSeptember 2018
  • Identification of Men with Low-Risk Biopsy-Confirmed Prostate Cancer as Candidates for Active Surveillance☆April 2018

Press Mentions

  • In Memoriam: Dr. Donald G. Skinner
    In Memoriam: Dr. Donald G. SkinnerAugust 12th, 2025
  • Focal Therapy for Prostate Cancer: Should It Become a Standard of Care?
    Focal Therapy for Prostate Cancer: Should It Become a Standard of Care?June 24th, 2022
  • EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™
    EDAP Hosting Key Opinion Leader Call on Focal One® and ExactVu™September 15th, 2020

Grant Support

  • Urologic Oncology Research Training GrantNational Cancer Institute2005–2011
  • Developmental Research ProgramNational Cancer Institute2006–2010
  • Career Development ProgramNational Cancer Institute2006–2010
  • Spore In Prostate CancerNational Cancer Institute2001–2008
  • Urology Oncology Research Training GrantNational Cancer Institute1999–2003

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: